Ongoing pharmaceutical reforms in France: Implications for key stakeholder groups

Catherine Sermet*, Veronique Andrieu, Brian Godman, Eric Van Ganse, Alan Haycox, Jean Pierre Reynier

*Corresponding author for this work

Research output: Contribution to journalComment/debate

94 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ongoing pharmaceutical reforms in France: Implications for key stakeholder groups'. Together they form a unique fingerprint.

Social Sciences

Business & Economics

Medicine & Life Sciences